Adenosine 5'-diphosphate-ribose is a neural regulator in primate and murine large intestine along with β-NAD +

Journal of Physiology

Volumn 590, Issue 8, 2012, Pages 1921-1941

  Durnin, Leonie ^a   Hwang, Sung Jin ^a   Ward, Sean M ^a   Sanders, Kenton M ^a   Mutafova Yambolieva, Violeta N ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 IODO 6 METHYLAMINO 9H PURIN 9 YL) 2 PHOSPHONOOXYBICYCLO[3.1.0]HEXANE 1 METHANOL; ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE TRIPHOSPHATE; APAMIN; INTESTINE ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE; PURINE NUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; COLON MOTILITY; CONTROLLED STUDY; ELECTRIC CONDUCTIVITY; ENZYME DEGRADATION; EVOKED BRAIN STEM RESPONSE; EXCITATORY JUNCTION POTENTIAL; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERPOLARIZATION; INHIBITORY POSTSYNAPTIC POTENTIAL; INTESTINE MUSCLE; MECHANICAL STIMULATION; METABOLITE; MICROELECTRODE; MOTONEURON; MOUSE; NERVE CELL STIMULATION; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTSYNAPTIC INHIBITION; PRIMATE; PRIORITY JOURNAL; REGULATORY MECHANISM; SENSITIVITY ANALYSIS;

ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE TRIPHOSPHATE; ANIMALS; COLON; GASTROINTESTINAL MOTILITY; MACACA FASCICULARIS; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH; MYOCYTES, SMOOTH MUSCLE; NAD; NEUROTRANSMITTER AGENTS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; PURINES; RECEPTORS, PURINERGIC P2Y1; SYNAPTIC TRANSMISSION;

EID: 84859717451     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.222414     Document Type: Article

References (42)

1. Abbracchio MP, Burnstock G, Verkhratsky A & Zimmermann H (2009). Purinergic signalling in the nervous system: an overview. Trends Neurosci 32, 19-29.
2. Agteresch HJ, Dagnelie PC, van den Berg JW & Wilson JH (1999). Adenosine triphosphate: established and potential clinical applications. Drugs 58, 211-232.
3. Beckett EA, Bayguinov YR, Sanders KM, Ward SM & Hirst GD (2004). Properties of unitary potentials generated by intramuscular interstitial cells of Cajal in the murine and guinea-pig gastric fundus. J Physiol 559, 259-269.
4. Bobalova J & Mutafova-Yambolieva VN (2001). Co-release of endogenous ATP and noradrenaline from guinea-pig mesenteric veins exceeds co-release from mesenteric arteries. Clin Exp Pharmacol Physiol 28, 397-401.
5. Bobalova J & Mutafova-Yambolieva VN (2003). Membrane-bound and releasable nucleotidase activities: differences in canine mesenteric artery and vein. Clin Exp Pharmacol Physiol 30, 194-202.
6. Bobalova J, Bobal P & Mutafova-Yambolieva VN (2002). High-performance liquid chromatographic technique for detection of a fluorescent analogue of adp-ribose in isolated blood vessel preparations. Anal Biochem 305, 269-276.
7. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM & Herman AG (1990). Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 345, 346-347.
8. Burns AJ, Lomax AE, Torihashi S, Sanders KM & Ward SM (1996). Interstitial cells of Cajal mediate inhibitory neurotransmission in the stomach. Proc Natl Acad Sci U S A 93, 12008-12013.
9. Burnstock G (2008). The journey to establish purinergic signalling in the gut. Neurogastroenterol Motil 20(Suppl 1), 8-19.
10. Burnstock G, Campbell G, Satchell D & Smythe A (1970). Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40, 668-688.
11. + metabolism. Biochem J 439, 341-348.
12. Di Girolamo M, Lupi R, Silletta MG, Turacchio S, Iurisci C, Luini A & Corda D (1997). Modulatory role of GTP-binding proteins in the endogenous ADP-ribosylation of cytosolic proteins. Adv Exp Med Biol 419, 343-347.
13. Gallego D, Hernandez P, Clave P & Jimenez M (2006). P2Y1 receptors mediate inhibitory purinergic neuromuscular transmission in the human colon. Am J Physiol Gastrointest Liver Physiol 291, G584-G594.
14. Gallego D, Gil V, Aleu J, Auli M, Clave P & Jimenez M (2008). Purinergic and nitrergic junction potential in the human colon. Am J Physiol Gastrointest Liver Physiol 295, G522-G533.
15. Gallego D, Gil V, Aleu J, Martinez-Cutillas M, Clave P & Jimenez M (2011). Pharmacological characterization of purinergic inhibitory neuromuscular transmission in the human colon. Neurogastroenterol Motil 23, 792-e338.
16. Graeff R, Liu Q, Kriksunov IA, Kotaka M, Oppenheimer N, Hao Q & Lee HC (2009). Mechanism of cyclizing NAD to cyclic ADP-ribose by ADP-ribosyl cyclase and CD38. J Biol Chem 284, 27629-27636.
17. Graeff RM, Franco L, De Flora A & Lee HC (1998). Cyclic GMP-dependent and -independent effects on the synthesis of the calcium messengers cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate. J Biol Chem 273, 118-125.
18. Gustafsson AJ, Muraro L, Dahlberg C, Migaud M, Chevallier O, Khanh HN, Krishnan K, Li N & Islam MS (2011). ADP ribose is an endogenous ligand for the purinergic P2Y1 receptor. Mol Cell Endocrinol 333, 8-19.
19. Hirst GDS, Bywater RAR, Teramoto N & Edwards FR (2004). An analysis of inhibitory junction potentials in the guinea-pig proximal colon. J Physiol 558, 841-855.
20. Hwang SJ, Durnin L, Dwyer L, Rhee PL, Ward SM, Koh SD, Sanders KM & Mutafova-Yambolieva VN (2011). β-Nicotinamide adenine dinucleotide is an enteric inhibitory neurotransmitter in human and nonhuman primate colons. Gastroenterology 140, 608-617.
21. 6-etheno-AMP as substrate, and comments on the properties of the reaction product, ethenoadenosine. Biochem J 250, 369-373.
22. i, and insulin secretion. J Biol Chem 274, 1869-72.
23. 11 receptors. Cell Calcium 46, 263-272.
24. Kurahashi M, Zheng H, Dwyer L, Ward SM, Don KS & Sanders KM (2011). A functional role for the 'fibroblast-like cells' in gastrointestinal smooth muscles. J Physiol 589, 697-710.
25. Lee HC (2001). Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu Rev Pharmacol Toxicol 41, 317-345.
26. Levitt B, Head RJ & Westfall DP (1984). High-pressure liquid chromatographic-fluorometric detection of adenosine and adenine nucleotides: application to endogenous content and electrically induced release of adenyl purines in guinea pig vas deferens. Anal Biochem 137, 93-100.
27. Mihaylova-Todorova S, Todorov LD & Westfall DP (2001). Correlation between the release of the sympathetic neurotransmitter atp and soluble nucleotidases from the guinea pig vas deferens. J Pharmacol Exp Ther 296, 64-70.
28. Munshi C, Aarhus R, Graeff R, Walseth TF, Levitt D & Lee HC (2000). Identification of the enzymatic active site of CD38 by site-directed mutagenesis. J Biol Chem 275, 21566-21571.
29. Mutafova-Yambolieva VN, Hwang SJ, Hao X, Chen H, Zhu MX, Wood JD, Ward SM & Sanders KM (2007). β-Nicotinamide adenine dinucleotide is an inhibitory neurotransmitter in visceral smooth muscle. Proc Natl Acad Sci U S A 104, 16359-16364.
30. Ortolan E, Vacca P, Capobianco A, Armando E, Crivellin F, Horenstein A & Malavasi F (2002). CD157, the Janus of CD38 but with a unique personality. Cell Biochem Funct 20, 309-322.
31. Sanders KM & Ward SM (1992). Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Am J Physiol Gastrointest Liver Physiol 262, G379-G392.
32. Sauve AA, Munshi C, Lee HC & Schramm VL (1998). The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries. Biochemistry 37, 13239-13249.
33. Secrist JA, Barrio JR, Leonard NJ & Weber G (1972). Fluorescent modification of adenosine-containing coenzymes. Biological activities and spectroscopic properties. Biochemistry 11, 3499-3506.
34. Serio R, Alessandro M, Zizzo MG, Tamburello MP & Mule F (2003). Neurotransmitters involved in the fast inhibitory junction potentials in mouse distal colon. Eur J Pharmacol 460, 183-190.
35. Smyth LM, Breen LT, Yamboliev IA & Mutafova-Yambolieva VN (2006). Novel localization of CD38 in perivascular sympathetic nerve terminals. Neuroscience 139, 1467-1477.
36. Smyth LM, Bobalova J, Mendoza MG, Lew C & Mutafova-Yambolieva VN (2004). Release of β-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder. J Biol Chem 279, 48893-48903.
37. Spencer NJ, Bywater RA, Holman ME & Taylor GS (1998). Inhibitory neurotransmission in the circular muscle layer of mouse colon. J Auton Nerv Syst 70, 10-14.
38. Todorov LD, Mihaylova-Todorova S, Westfall TD, Sneddon P, Kennedy C, Bjur RA & Westfall DP (1997). Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 387, 76-79.
39. von Kugelgen I (2006). Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110, 415-432.
40. Westfall TD, Sarkar S, Ramphir N, Westfall DP, Sneddon P & Kennedy C (2000). Characterization of the ATPase released during sympathetic nerve stimulation of the guinea-pig isolated vas deferens. Br J Pharmacol 129, 1684-1688.
41. Zimmermann H, Braun N, Kegel B & Heine P (1998). New insights into molecular structure and function of ectonucleotidases in the nervous system. Neurochem Int 32, 421-425.
42. Zimmermann H (2000). Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362, 299-309.